Literature DB >> 20527645

Sero-epidemiological study of visceral leishmaniasis in Basrah, Southern Iraq.

Zainab Hameed Gani1, Meaad Kadhum Hassan, Abdul-Mohsin Hameed Jassim.   

Abstract

OBJECTIVES: To study selected epidemiological aspects of visceral leishmaniasis, assess direct agglutination test (DAT) as a diagnostic method and the sero-epidemiological prevalence of the disease among apparently healthy children in Basrah, Iraq.
METHODS: This prospective study included 146 children suspected of visceral leishmaniasis who were admitted to Basrah Maternity and Children Hospital and Basrah General Hospital from November 2004 till November 2005 and 37 serum samples that were collected from patients with different diseases considered in the differential diagnosis of visceral leishmaniasis. In addition, 1000 apparently healthy children were randomly selected for the sero-epidemiological survey. Direct agglutination test was done for all of them.
RESULTS: Out of 146 suspected visceral leishmaniasis cases, 124 (84.9%) were proved by the examination of bone marrow aspirate, 132 (91.1%) were positive by direct agglutination test (DAT) and only 3 (2%) were positive by immunochromatographic strip test. The sensitivity and specificity of DAT were (100%), with a cut-off point of 1:800. In the in-patient group children less than 2 years of age were mainly affected. The highest frequency of disease was reported in July, 24 cases (18.8%). Sand flies were recorded in the environment of all sero-positive cases (100%) in each group, stray dogs and wild canines were present in (75.7% and 15.5%) in in-patients group compared to (69% and 22.5%) in sero-epidemiological group, respectively. Low maternal education was present in a significantly higher frequency among sero-positive cases.
CONCLUSIONS: Direct agglutination test can be used as a screening tool for visceral leishmaniasis on a wide range in endemic areas, with a high sensitivity and specificity.

Entities:  

Mesh:

Year:  2010        PMID: 20527645

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  7 in total

1.  Correlation of Rk39-Specific Antibodies and Thyroid Function in Patients with Visceral Leishmaniasis.

Authors:  Ali Ibrahim Ali Al-Ezzy; Walaa Najm Abood
Journal:  Eurasian J Med       Date:  2016-10

2.  Seroepidemiological study on visceral leishmaniasis in an endemic focus of central Iran during 2017.

Authors:  Leyli Zanjirani Farahani; Mehdi Mohebali; Behnaz Akhoundi; Abedin Saghafipour; Zahra Kakooei
Journal:  J Parasit Dis       Date:  2018-11-10

3.  Seroepidemiological survey of human visceral leishmaniasis in ilam province, west of iran in 2013.

Authors:  Jahangir Abdi; Behnaz Akhoundi; Mehdi Mohebali; Abolhasan Ghaderipour; Zahra Kakoee; Faezeh Najafi
Journal:  Iran J Parasitol       Date:  2015 Jan-Mar       Impact factor: 1.012

Review 4.  Leishmaniasis in the middle East: incidence and epidemiology.

Authors:  Nasir Salam; Waleed Mohammed Al-Shaqha; Arezki Azzi
Journal:  PLoS Negl Trop Dis       Date:  2014-10-02

5.  The diagnostic accuracy of direct agglutination test for serodiagnosis of human visceral leishmaniasis: a systematic review with meta-analysis.

Authors:  Mehdi Mohebali; Hossein Keshavarz; Sedigheh Shirmohammad; Behnaz Akhoundi; Alireza Borjian; Gholamreza Hassanpour; Setareh Mamishi; Shima Mahmoudi
Journal:  BMC Infect Dis       Date:  2020-12-11       Impact factor: 3.090

6.  Visceral Leishmaniasis in Ardabil Province, Northwest of Iran: A Retrospective Epidemiological, Clinical and Paraclinical Study (1985-2018).

Authors:  Soheila Molaei; Hamed Zandian; Akbar Molaie; Telma Zahirian; Mehdi Mohebali; Zabih Zareie; Babak Nakhostin; Dariush Emdadi; Behnaz Akhoundi; Seyyedeh-Negar Modares-Sadrani; Hamed Abdollahzadeh; Zahra Rakhshidan; Ezati Ezati; Zahra Heidari
Journal:  Iran J Public Health       Date:  2022-08       Impact factor: 1.479

7.  Asymptomatic Leishmania Infected Children: A Seroprevalence and Molecular Survey in a Rural Area of Fars Province, Southern Iran.

Authors:  Akram Layegh Gigloo; Bahador Sarkari; Zahra Rezaei; Gholam Reza Hatam; Mohammad Hassan Davami
Journal:  J Trop Med       Date:  2018-05-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.